| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| Other Sizes |
| Targets |
NSP-DMAE-NHS does not have a defined pharmacological target as it is a chemiluminescent reagent and diagnostic tool. The compound is an acridinium ester chemiluminescent reagent that can be covalently linked to biomolecules (e.g., proteins, antibodies, nucleic acids) to enhance detection sensitivity. Its NHS ester moiety reacts with amine groups to form stable amide bonds.
|
|---|---|
| ln Vitro |
In vitro activity of NSP-DMAE-NHS is assessed in chemiluminescent immunoassays. The compound serves as a chemiluminescent label for biomolecules, enabling highly sensitive detection in diagnostic assays. In alkaline H₂O₂ solution, the acridinium ester forms an unstable dioxetane that decomposes to CO₂ and electronically excited N-methylacridone, producing light. The compound is used in clinical diagnostics for immunochemical analysis.
|
| ln Vivo |
No specific in vivo pharmacological activity data have been documented for NSP-DMAE-NHS as a therapeutic agent. The compound is used as a chemiluminescent reagent in clinical diagnostics and research applications. It is not administered to animals for pharmacological evaluation. Its applications are limited to in vitro diagnostic assays.
|
| Enzyme Assay |
For non-cellular assays, NSP-DMAE-NHS is characterized by standard analytical techniques including HPLC, NMR, and mass spectrometry to confirm identity and purity. The compound has a molecular weight of 590.6 and formula C₃₀H₂₆N₂O₉S. Storage: keep in a cool, dry place protected from light and moisture. Typical protocols involve conjugating the NHS ester to amine-containing biomolecules for chemiluminescent labeling.
|
| Cell Assay |
For in vitro cell-based studies, NSP-DMAE-NHS is not typically used as a direct test compound. It is used as a chemiluminescent labeling reagent for diagnostic assays. If handled in a biological laboratory context, standard safety precautions should be taken. The compound is light-sensitive and should be protected from light during storage and handling.
|
| Animal Protocol |
For in vivo animal studies, NSP-DMAE-NHS is not typically administered as a test compound. It is used as a chemiluminescent reagent for in vitro diagnostic applications. If used in animal studies for specific research purposes, it would be administered via appropriate routes with suitable formulations.
|
| ADME/Pharmacokinetics |
NSP-DMAE-NHS has a molecular weight of 590.6 and formula C₃₀H₂₆N₂O₉S. Storage: keep in a cool, dry place protected from light and moisture. The compound is an acridinium ester chemiluminescent reagent containing N-sulfopropyl groups. Purity: typically ≥95%.
|
| Toxicity/Toxicokinetics |
NSP-DMAE-NHS is for research and diagnostic use only and not for human consumption. Standard laboratory safety practices should be followed when handling this chemical. Appropriate personal protective equipment including gloves and safety glasses should be worn. Specific LD₅₀ values and detailed toxicological profiles have not been extensively reported.
|
| Additional Infomation |
NSP-DMAE-NHS (CAS 194357-64-7) is an acridinium ester chemiluminescent reagent containing N-sulfopropyl groups. It is useful in the clinical diagnostics industry, particularly in automated immunochemistry analyzers such as Siemens Healthcare Diagnostics' ADVIA Centaur system. The NHS ester moiety reacts with amine groups to form stable amide bonds. No clinical trials or therapeutic approvals exist.
|
| Molecular Formula |
C30H26N2O9S
|
|---|---|
| Molecular Weight |
590.60
|
| Exact Mass |
590.136
|
| CAS # |
194357-64-7
|
| PubChem CID |
20608334
|
| Appearance |
Light yellow to green yellow solid powder
|
| LogP |
4.291
|
| Hydrogen Bond Donor Count |
0
|
| Hydrogen Bond Acceptor Count |
9
|
| Rotatable Bond Count |
9
|
| Heavy Atom Count |
42
|
| Complexity |
1090
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
C(C1C2=CC=CC=C2[N+](CCCS([O-])(=O)=O)=C2C=CC=CC=12)(=O)OC1C(=CC(C(=O)ON2C(CCC2=O)=O)=CC=1C)C
|
| InChi Key |
AAYSIOJYGRABGS-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C30H26N2O9S/c1-18-16-20(29(35)41-32-25(33)12-13-26(32)34)17-19(2)28(18)40-30(36)27-21-8-3-5-10-23(21)31(14-7-15-42(37,38)39)24-11-6-4-9-22(24)27/h3-6,8-11,16-17H,7,12-15H2,1-2H3
|
| Chemical Name |
3-[9-[4-(2,5-dioxopyrrolidin-1-yl)oxycarbonyl-2,6-dimethylphenoxy]carbonylacridin-10-ium-10-yl]propane-1-sulfonate
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.6932 mL | 8.4660 mL | 16.9319 mL | |
| 5 mM | 0.3386 mL | 1.6932 mL | 3.3864 mL | |
| 10 mM | 0.1693 mL | 0.8466 mL | 1.6932 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
